Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis. Gross CC, Ahmetspahic D, Ruck T, Schulte-Mecklenbeck A, Schwarte K, Jörgens S, Scheu S, Windhagen S, Graefe B, Melzer N, et al. Neurol Neuroimmunol Neuroinflamm. 2016 Dec; 3(6):e289. PMID: 27766281. Abstract CommentRecommendBookmarkWatch